HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
Click here to view/purchase Issue PDF
Vol 18, No 10, October 2014 - Clinical Trials
Contents

EDITORIAL

BioBoard

JAPAN
•  Study notes widening disease transmission by monkeys

MALAYSIA
•  Drug-resistant malaria threatens control programs

SINGAPORE
•  Novel gene predicts both breast cancer relapse and response to chemotherapy
•  New drug formulations to boost fight against respiratory illnesses and antibiotic-resistant superbugs
•  Zebrafish genes linked to human respiratory diseases
•  Singapore researchers discover a gene that increases incidence of acute myelogenous leukemia
•  Scientists develop green tea-based 'missiles' to kill cancer cells more effectively

UNITED STATES
•  Large study reveals new genetic variants that raise risk for prostate cancer
•  Math model designed to replace invasive kidney biopsy for lupus patients
•  Mayo Clinic researchers reveal pathway that contributes to Alzheimer’s disease
•  Immunotherapy combination demonstrates superior anti-cancer activity

EYE ON CHINA
•  Milestone Scientific and Milestone China form new dermatological joint venture
•  BGI and The Vancouver Prostate Centre to create joint research laboratory for advancement of translational cancer research
•  BGI Tech, DLF-Trifolium A/S, and Aarhus University applying genomic selection methods to enhance forage grass varieties
•  Ioxus to be incorporated in China as Ioxus (Shanghai) Clean Energy Technology
•  Tsinghua and UC Berkeley launch research and graduate education partnership
•  Altor BioScience and Shenzhen Beike Biotechnology enter license agreement for immunotherapeutic ALT-803 in China
•  3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China

FEATURES
•  Site Mapping the Innovative Way
•  The Art of Site Selection – How Sites Without Trials Experience Could Help Bolster Study Performance
•  Become Greats through GREATS
•  Unraveling Heart Failure: Looking at an Asian Phenotype
•  Recognizing Opportunities Amidst Biopharma Challenges in China

PEOPLE WATCH
•  Tackling Resistance with RNA

INSIDE INDUSTRY
•  Innovation in Academic Medicine
•  Merck Serono awards Grant for Growth Innovation (GGI) for the first time
•  National Cancer Institute awards KIYATEC nearly $2M to fund 3D breast cancer, 3D brain cancer micro-tumor development
•  Frost & Sullivan honors 2014 Growth, Innovation & Leadership Award winners
•  Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia’s Children’s Cancer Institute
•  Daiichi Sankyo further expands TaNeDS collaborative drug discovery program in Europe
•  Veolia Water Technologies South-East Asia to provide advanced water solutions for Tun Razak Exchange Project in Malaysia
•  Biocept and Rosetta Genomics collaborate to evaluate microRNAs from circulating tumor cells
•  Biocept expands collaboration with MD Anderson Cancer Center

•  CONFERENCE CALENDAR

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy